Research programme: melanin-concentrating hormone receptor 1 antagonists - GlaxoSmithKline
Alternative Names: GW 3430; GW 803430; GW 803430ALatest Information Update: 18 Apr 2011
At a glance
- Originator GlaxoSmithKline
- Class Pyrimidinones; Pyrrolidines; Small molecules
- Mechanism of Action MCHR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity